Patent · US Active

Composition containing creatine fatty ester for use in medicine

US12403113B2 · kind B2 · utility

0Cited by

0References

13Claims

0Family size

Assignee

COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES · FR

Inventors

Aloïse Mabondzo · Paris, FR
Gabriela Ullio-Gamboa · Damiette, FR
Anne-Cécile Guyot
Sophie Dezard · Le Chardonnet, FR
Frederic Taran · Damiette, FR
Henri Benech · Paris, FR
Olivier Loreau · La Clappe, FR

Key dates

Filing date	Apr 29, 2020
Grant date	Sep 2, 2025
Priority date	—
Expiry date	Dec 31, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A composition comprising at least one creatine fatty ester or salt thereof, at least one omega 3 fatty acid or salt thereof and at least one glyceride for use in medicine, the composition being free of non ionic surfactants and in particular said composition for use in treating the brain creatine transporter deficiency disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.